Bright Minds BiosciencesDRUG

13F holders, Q2 2025 (June 30)
47holders +13
22new positions
9sold out
2famous investors
$26.16avg. 13F price*

At the end of Q2 2025, 47 institutions reported holding Bright Minds Biosciences Inc. (DRUG) in their 13F filings, up 13 from Q1 2025. 22 opened new positions and 9 sold out. The largest holders were Janus Henderson Group PLC ($30.2M), Cormorant Asset Management, LP ($27.7M) and Sio Capital Management, LLC ($13.4M). 2 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Bright Minds Biosciences Inc.
CUSIP
10919W405
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080100 Q1 2024: 7Q1 2024Q2 2024: 6Q2 2024Q3 2024: 6Q3 2024Q4 2024: 31Q4 2024Q1 2025: 34Q1 2025Q2 2025: 47Q2 2025Q3 2025: 64Q3 2025Q4 2025: 74Q4 2025Q1 2026: 94Q1 2026Q2 2026: 99Q2 2026

Total Exit/New Position Q1 2025 → Q2 2025

InstitutionsTotal Value
New Positions22$5.7M
Exits9$10.6M

All 13F filers, Q1 2025 → Q2 2025: 479,821 shares bought and 460,639 shares sold, net +19,182 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 47 holders

Janus Henderson Group PLC 0.01% Add +3.1% 1,145,660 $30.2M
Cormorant Asset Management, LP 2.06% No change 1,059,331 $27.7M
Sio Capital Management, LLC 5.37% Add +0.9% 512,338 $13.4M
Commodore Capital LP 0.92% No change 500,000 $13.1M
Perceptive Advisors LLC 0.41% Reduce -5.4% 420,690 $11.0M
Vivo Capital, LLC 0.67% No change 251,572 $6.6M
BlackRock, Inc. 0.00% Add +30825.8% 209,677 $5.5M
Adage Capital Partners Gp, L.L.C. 0.01% No change 200,000 $5.2M
Morgan Stanley 0.00% Add +3.5% 162,069 $4.2M
Point72 Asset Management 0.01% No change 135,020 $3.5M
Millennium Management 0.00% Reduce -42.2% 111,371 $2.9M
Schonfeld Strategic Advisors LLC 0.01% Reduce -8.7% 69,004 $1.8M
Ikarian Capital, LLC 0.57% No change 65,431 $1.7M
Geode Capital Management, LLC 0.00% New 57,521 $1.5M
Walleye Capital LLC 0.01% Reduce -37.2% 53,430 $1.4M
Acuta Capital Partners, LLC 1.77% Reduce -18.9% 48,474 $1.3M
Vanguard Group Inc. 0.00% New 31,983 $835K
Platinum Investment Management Ltd. 0.05% No change 28,308 $739K
Northern Trust Corp. 0.00% New 25,626 $669K
State Street Corp. 0.00% New 24,655 $644K
Boothbay Fund Management, LLC 0.02% No change 19,164 $500K
AdvisorShares Investments LLC 0.07% Add +28.4% 14,481 $378K
Readystate Asset Management LP 0.03% New 13,975 $365K
Nuveen, LLC 0.00% New 12,487 $326K
Charles Schwab Investment Management Inc. 0.00% New 11,604 $303K
Bank of New York Mellon Corp 0.00% New 8,702 $227K
Barclays PLC 0.00% New 8,393 $219K
Rhumbline Advisers 0.00% New 6,612 $173K
Deutsche Bank AG 0.00% New 5,486 $143K
Bank of America Corp. 0.00% Reduce -12.6% 4,734 $124K
New York State Common Retirement Fund 0.00% New 4,100 $107K
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 0.00% New 2,513 $66K
Wells Fargo & Company 0.00% New 2,378 $62K
UBS Group AG 0.00% Reduce -83.4% 1,914 $50K
Citigroup Inc. 0.00% Add +163100.0% 1,632 $43K
Police & Firemen's Retirement System of New Jersey 0.00% New 1,079 $28K
STRS Ohio 0.00% New 900 $23K
JPMorgan Chase & Co. 0.00% Add +624.3% 2,173 $17K
Legal & General Group Plc 0.00% New 513 $14K
Ameritas Investment Partners, Inc. 0.00% New 470 $12K
BNP Paribas Financial Markets 0.00% Reduce -58.5% 457 $12K
California State Teachers Retirement System 0.00% New 287 $7K
Amalgamated Bank 0.00% New 157 $4K
FMR LLC 0.00% New 79 $2K
Royal Bank of Canada 0.00% Reduce -89.0% 65 $2K
SBI Securities Co., Ltd. 0.00% No change 55 $1K
Sterling Capital Management LLC 0.00% New 11 $287

"% of holder's portfolio" is DRUG's weight in each manager's 13F, not the share of Bright Minds Biosciences Inc. the manager owns.